The Overall Survival and Safety of Men with Metastatic Hormone-Sensitive Prostate Cancer Treated with Combination Therapy of Novel Androgen Receptor Antagonists and Androgen-Deprivation Therapy: A Systematic Review and Meta-Analysis

Table 5

Publication bias by Egger’s test and Beggar’s test.

Outcomes indicators	No. of studies	of Egger’s test	of Beggar’s test
OS	6	0.177	0.573
PFS	6	0.865	0.851
Any AE	6	0.703	0.348
Grade 3 or 4 AE	6	0.090	0.188
Any serious AEs	5	0.641	0.892
AEs leading to death	4	0.728	0.497

OS, overall survival; PFS, progression-free survival; AE, adverse event.